G1 Therapeutics Inc (GTHX)
4.43
+0.30
(+7.26%)
USD |
NASDAQ |
May 02, 16:00
4.43
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Gross Profit Margin (Quarterly): 91.56% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.56% |
| September 30, 2023 | 74.99% |
| June 30, 2023 | 96.69% |
| March 31, 2023 | 88.73% |
| December 31, 2022 | 90.32% |
| September 30, 2022 | 95.29% |
| Date | Value |
|---|---|
| June 30, 2022 | 90.77% |
| March 31, 2022 | 90.31% |
| December 31, 2021 | 93.55% |
| September 30, 2021 | 87.83% |
| June 30, 2021 | 87.76% |
| March 31, 2021 | 98.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
74.99%
Minimum
Sep 2023
98.29%
Maximum
Mar 2021
90.51%
Average
90.55%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 90.16% |
| Geron Corp | -- |
| Palatin Technologies Inc | 95.20% |
| Oragenics Inc | -- |
| TG Therapeutics Inc | 82.14% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.05% |
| Return on Assets | -31.87% |
| Return on Invested Capital | -42.99% |
| Profit Margin (Quarterly) | -73.14% |
| Operating Margin (Quarterly) | -60.04% |
| Return on Net Operating Assets | -140.0% |